NEW YORK (dpa-AFX) - U.S. investment bank Bank of America ( BofA ) has added Merck KGaA shares to its "Europe 1" recommendation list and considers them a "top pick" in the EU pharmaceuticals sector. The rating was left at "Buy" with a price target of 215 euros. The papers of the pharmaceuticals and specialty chemicals group are worth buying for several reasons, analyst Sachin Jain wrote in a study presented Wednesday. He pointed to the positive outlook for the multiple sclerosis drug evobrutinib, the attractive valuation and potential acquisitions as potential share price drivers./edh/ck

Publication of the original study: 04.01.2023 / 00:30 / EST First disclosure of the original study: 04.01.2023 / 00:30 / EST

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------